Trial Profile
Clinical Trials Insight: 700028180
Status:
Not stated
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2007
Price :
$35
*
At a glance
- Drugs Erlotinib (Primary)
- Indications Biliary cancer; Liver cancer
- Focus Therapeutic Use
- Sponsors OSI Pharmaceuticals
- 06 Nov 2007 New trial record.